DCTHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
DELCATH SYSTEMS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$14.37+0.29 (+2.06%)
Close on Oct 19, 2026
- Market cap
- $571.37M
- P/E (TTM)
- 1437.0
- Dividend yield
- –
DELCATH SYSTEMS, INC. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HEPZATO KIT | $78.84M | $32.30M | $0 | – | – | – | – | – | – | 92.5% | +144.0% |
| CHEMOSAT | $6.40M | $4.90M | $2.07M | – | – | – | – | – | – | 7.5% | +30.5% |
| Product revenue | – | – | $2.07M | $2.55M | $1.30M | $1.16M | $1.10M | $3.38M | $2.72M | – | – |
| Other revenue | – | – | $0 | $171.00K | $2.26M | $490.00K | $479.00K | $29.00K | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $78.84M | $32.30M | – | – | – | – | – | – | – | 92.5% | +144.0% |
| Foreign | $6.40M | $4.90M | – | – | – | – | – | – | – | 7.5% | +30.5% |
From the segment and revenue-disaggregation notes of Delcath Systems's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.